Renal systems biology of patients with systemic inflammatory response syndrome

Kidney International

Volumn 88, Issue 4, 2015, Pages 804-814

  Tsalik, Ephraim L ^a,b,c   Willig, Laurel K ^d   Rice, Brandon J ^e,f   Van Velkinburgh, Jennifer C ^e   Mohney, Robert P ^g   McDunn, Jonathan E ^g   Dinwiddie, Darrell L ^e,h   Miller, Neil A ^d   Mayer, Eric S ^g   Glickman, Seth W ⁱ   Jaehne, Anja K ^j   Glew, Robert H ^h   Sopori, Mohan L ^k   Otero, Ronny M ^j,l   Harrod, Kevin S ^k   Cairns, Charles B ⁱ   Fowler, Vance G ^b   Rivers, Emanuel P ^j   Woods, Christopher W ^a,b,c   Kingsmore, Stephen F ^d,e   Langley, Raymond J ^e,k   more..

^a DURHAM VA MEDICAL CENTER   (United States)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

^c DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d CHILDREN S MERCY HOSPITAL   (United States)

^e NATIONAL CENTER FOR GENOME RESOURCES   (United States)

^f UNIVERSITY OF CALIFORNIA   (United States)

^g METABOLON INC   (United States)

^h UNIVERSITY OF NEW MEXICO SCHOOL OF MEDICINE   (United States)

ⁱ UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^j HENRY FORD HOSPITAL   (United States)

^k LOVELACE RESPIRATORY RESEARCH INSTITUTE   (United States)

^l UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

more..

Author keywords

acute kidney injury; chronic kidney disease; gene expression; hemodialysis; sepsis

Indexed keywords

ALLANTOIN; AMIDE; LOW MOLECULAR WEIGHT PROTEIN; MEMBRANE PROTEIN; N ACETYLASPARTIC ACID; N1 METHYL 4 PYRIDONE 3 CARBOXAMIDE; NUCLEOSIDE; PENTOSE PHOSPHATE; PROTEIN RNASE1; PROTEOME; RIBONUCLEASE; RIBONUCLEOTIDE; TRANSCRIPTOME; UNCLASSIFIED DRUG; BIOLOGICAL MARKER; MESSENGER RNA; PLASMA PROTEIN;

ACUTE KIDNEY FAILURE; AMINO ACID METABOLISM; ARTICLE; CATABOLISM; CONTROLLED STUDY; CRITICAL ILLNESS; DISEASE ASSOCIATION; DOWN REGULATION; HEMODIALYSIS; HUMAN; IMMUNE RESPONSE; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; METABOLOME; OBSERVATIONAL STUDY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SYSTEM ANALYSIS; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; SYSTEMS BIOLOGY; UREMIA; URINARY EXCRETION; URINE RETENTION; ACUTE KIDNEY INJURY; ADULT; AGED; BLOOD; CLINICAL TRIAL; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETICS; KIDNEY; KIDNEY FUNCTION TEST; MALE; METABOLISM; METABOLOMICS; MIDDLE AGED; MULTICENTER STUDY; PATHOPHYSIOLOGY; PROTEOMICS; TIME FACTOR; TREATMENT OUTCOME; UNITED STATES; VERY ELDERLY;

ACUTE KIDNEY INJURY; ADULT; AGED; AGED, 80 AND OVER; BIOMARKERS; BLOOD PROTEINS; CRITICAL ILLNESS; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HUMANS; KIDNEY; KIDNEY FUNCTION TESTS; MALE; METABOLOMICS; MIDDLE AGED; PROTEOMICS; RENAL DIALYSIS; RNA, MESSENGER; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; SYSTEMS BIOLOGY; SYSTEMS INTEGRATION; TIME FACTORS; TREATMENT OUTCOME; UNITED STATES;

EID: 84942982512     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1038/ki.2015.150     Document Type: Article

References (65)

1. Meyer TW, Hostetter TH. Uremia. N Engl J Med 2007; 357: 1316-1325.
2. Himmelfarb J, Ikizler TA. Hemodialysis. N Engl J Med 2010; 363: 1833-1845.
3. Vanholder R, De Smet R, Glorieux G et al. Review on uremic toxins: classification, concentration, and interindividual variability. Kidney Int 2003; 63: 1934-1943.
4. Langley RJ, Tsalik EL, Velkinburgh JC et al. An integrated clinicometabolomic model improves prediction of death in sepsis. Sci Transl Med 2013; 5: 195ra195.
5. Tenenbaum JD, Christian V, Cornish MA et al. The MURDOCK Study: A long-term initiative for disease reclassification through advanced biomarker discovery and integration with electronic health records. Am J Transl Res 2012; 4: 291-301.
6. Tsalik EL, Jaggers LB, Glickman SW et al. Discriminative value of inflammatory biomarkers for suspected sepsis. J Emerg Med 2012; 43: 97-106.
7. Ahn SH, Tsalik EL, Cyr DD et al. Gene expression-based classifiers identify Staphylococcus aureus infection in mice and humans. PLoS One 2013; 8: e48979.
8. Tsalik EL, Jones D, Nicholson B et al. Multiplex PCR to diagnose bloodstream infections in patients admitted from the emergency department with sepsis. J Clin Microbiol 2010; 48: 26-33.
9. Zaas AK, Burke T, Chen M et al. A host-based RT-PCR gene expression signature to identify acute respiratory viral infection. Sci Transl Med 2013; 5: 203ra126.
10. Mudge J, Miller NA, Khrebtukova I et al. Genomic convergence analysis of schizophrenia: mRNA sequencing reveals altered synaptic vesicular transport in post-mortem cerebellum. PLoS One 2008; 3: e3625.
11. Glickman SW, Cairns CB, Otero RM et al. Disease progression in hemodynamically stable patients presenting to the emergency department with sepsis. Acad Emerg Med 2010; 17: 383-390.
12. Mehta RL, Kellum JA, Shah SV et al. Acute kidney injury network: report of an initiative to improve outcomes in acute kidney injury. Crit Care 2007; 11: R31.
13. Storey JD. A direct approach to false discovery rates. R Stat Soc Ser B 2002; 64: 479-498.
14. Storey JD, Taylor JE, Siegmund D. Strong control, conservative point estimation and simultaneous conservative consistency of false discovery rates: A unified approach. J R Stat Soc Ser B 2004; 66: 187-205.
15. Puthucheary ZA, Rawal J, McPhail M et al. Acute skeletal muscle wasting in critical illness. JAMA 2013; 310: 1591-1600.
16. Brusilow SW. Phenylacetylglutamine may replace urea as a vehicle for waste nitrogen excretion. Pediatr Res 1991; 29: 147-150.
17. Lesaffer G, De Smet R, Lameire N et al. Intradialytic removal of proteinbound uraemic toxins: role of solute characteristics and of dialyser membrane. Nephrol Dial Transplant 2000; 15: 50-57.
18. Dorman HR, Sondheimer JH, Cadnapaphornchai P. Mannitol-induced acute renal failure. Medicine (Baltimore, MD) 1990; 69: 153-159.
19. Visweswaran P, Massin EK, Dubose TD Jr. Mannitol-induced acute renal failure. J Am Soc Nephrol 1997; 8: 1028-1033.
20. Park JS, Kim GH, Kang CM et al. Application of cystatin C reduction ratio to high-flux hemodialysis as an alternative indicator of the clearance of middle molecules. Korean J Intern Med 2010; 25: 77-81.
21. Gansler J, Preissner KT, Fischer S. Influence of proinflammatory stimuli on the expression of vascular ribonuclease 1 in endothelial cells. FASEB J 2014; 28: 752-760.
22. Johnson RJ, Lanaspa MA, Gaucher EA. Uric acid: A danger signal from the RNA world that may have a role in the epidemic of obesity, metabolic syndrome, and cardiorenal disease: evolutionary considerations. Semin Nephrol 2011; 31: 394-399.
23. Rutkowski B, Slominska E, Szolkiewicz M et al. N-methyl-2-pyridone-5-carboxamide: A novel uremic toxin? Kidney Int Suppl 2003: S19-S21.
24. Slominska EM, Kowalik K, Smolenski RT et al. Accumulation of poly(ADPribose) polymerase inhibitors in children with chronic renal failure. Pediatr Nephrol 2006; 21: 800-806.
25. Moffett JR, Arun P, Ariyannur PS et al. N-acetylaspartate reductions in brain injury: impact on post-injury neuroenergetics, lipid synthesis, and protein acetylation. Front Neuroenerget 2013; 5: 11.
26. Tryc AB, Alwan G, Bokemeyer M et al. Cerebral metabolic alterations and cognitive dysfunction in chronic kidney disease. Nephrol Dial Transplant 2011; 26: 2635-2641.
27. Vanholder R, Van Laecke S, Glorieux G. What is new in uremic toxicity? Pediatr Nephrol 2008; 23: 1211-1221.
28. Jourde-Chiche N, Dou L, Cerini C et al. Vascular incompetence in dialysis patients-protein-bound uremic toxins and endothelial dysfunction. Semin Dial 2011; 24: 327-337.
29. Scholze A, Jankowski V, Henning L et al. Phenylacetic acid and arterial vascular properties in patients with chronic kidney disease stage 5 on hemodialysis therapy. Nephron Clin Pract 2007; 107: c1-c6.
30. Zarjou A, Agarwal A. Sepsis and acute kidney injury. J Am Soc Nephrol 2011; 22: 999-1006.
31. El Nahas M. The global challenge of chronic kidney disease. Kidney Int 2005; 68: 2918-2929.
32. Niewczas MA, Sirich TL, Mathew AV et al. Uremic solutes and risk of endstage renal disease in type 2 diabetes: metabolomic study. Kidney Int 2014.
33. Small DM, Coombes JS, Bennett N et al. Oxidative stress, anti-oxidant therapies and chronic kidney disease. Nephrology 2012; 17: 311-321.
34. Small DM, Bennett NC, Roy S et al. Oxidative stress and cell senescence combine to cause maximal renal tubular epithelial cell dysfunction and loss in an in vitro model of kidney disease. Nephron Exp Nephrol 2012; 122: 123-130.
35. Watanabe H, Miyamoto Y, Honda D et al. p-Cresyl sulfate causes renal tubular cell damage by inducing oxidative stress by activation of NADPH oxidase. Kidney Int 2013; 83: 582-592.
36. Dou L, Jourde-Chiche N, Faure V et al. The uremic solute indoxyl sulfate induces oxidative stress in endothelial cells. J Thromb Haemost 2007; 5: 1302-1308.
37. Niwa T. Removal of protein-bound uraemic toxins by haemodialysis. Blood Purif 2013; 35(Suppl 2): 20-25.
38. Yu M, Kim YJ, Kang DH. Indoxyl sulfate-induced endothelial dysfunction in patients with chronic kidney disease via an induction of oxidative stress. Clin J Am Soc Nephrol 2011; 6: 30-39.
39. Fujii H, Nakai K, Fukagawa M. Role of oxidative stress and indoxyl sulfate in progression of cardiovascular disease in chronic kidney disease. Ther Apher Dial 2011; 15: 125-128.
40. Gomez H, Ince C, De Backer D et al. A unified theory of sepsis-induced acute kidney injury: inflammation, microcirculatory dysfunction, bioenergetics, and the tubular cell adaptation to injury. Shock 2014; 41: 3-11.
41. Bragadottir G, Redfors B, Ricksten SE. Mannitol increases renal blood flow and maintains filtration fraction and oxygenation in postoperative acute kidney injury: A prospective interventional study. Crit Care 2012; 16: R159.
42. Diringer MN, Zazulia AR. Osmotic therapy: fact and fiction. Neurocrit Care 2004; 1: 219-233.
43. Dickenmann M, Oettl T, Mihatsch MJ. Osmotic nephrosis: Acute kidney injury with accumulation of proximal tubular lysosomes due to administration of exogenous solutes. Am J Kidney Dis 2008; 51: 491-503.
44. Fang L, You H, Chen B et al. Mannitol is an independent risk factor of acute kidney injury after cerebral trauma: A case-control study. Ren Fail 2010; 32: 673-679.
45. Kuper C, Beck FX, Neuhofer W. NFAT5 contributes to osmolality-induced MCP-1 expression in mesothelial cells. Mediat Inflamm 2012; 2012: 513015.
46. Hsu SI, Couser WG. Chronic progression of tubulointerstitial damage in proteinuric renal disease is mediated by complement activation: A therapeutic role for complement inhibitors? J Am Soc Nephrol 2003; 14: S186-S191.
47. Kakoki M, Smithies O. The kallikrein-kinin system in health and in diseases of the kidney. Kidney Int 2009; 75: 1019-1030.
48. van den Brand JA, Hofstra JM, Wetzels JF. Low-molecular-weight proteins as prognostic markers in idiopathic membranous nephropathy. Clin J Am Soc Nephrol 2011; 6: 2846-2853.
49. Balla S, Nusair MB, Alpert MA. Risk factors for atherosclerosis in patients with chronic kidney disease: recognition and management. Curr Opin Pharmacol 2013; 13: 192-199.
50. Turner CM, Arulkumaran N, Singer M et al. Is the inflammasome a potential therapeutic target in renal disease? BMC Nephrol 2014; 15: 21.
51. Hotchkiss RS, Tinsley KW, Swanson PE et al. Sepsis-induced apoptosis causes progressive profound depletion of B and CD4+ T lymphocytes in humans. J Immunol 2001; 166: 6952-6963.
52. Lisowska KA, Debska-Slizien A, Jasiulewicz A et al. Influence of hemodialysis on circulating CD4(low)CD25 (high) regulatory T cells in end-stage renal disease patients. Inflamm Res 2014; 63: 99-103.
53. Betjes MG, Langerak AW, van der Spek A et al. Premature aging of circulating T cells in patients with end-stage renal disease. Kidney Int 2011; 80: 208-217.
54. Barrabes S, Pages-Pons L, Radcliffe CM et al. Glycosylation of serum ribonuclease 1 indicates a major endothelial origin and reveals an increase in core fucosylation in pancreatic cancer. Glycobiology 2007; 17: 388-400.
55. Cabrera-Fuentes HA, Niemann B, Grieshaber P et al. RNase1 as a potential mediator of remote ischaemic preconditioning for cardioprotection. Eur J Cardiothorac Surg 2015. (doi:10. 1093/ejcts/ezu519).
56. Synesiou E, Fairbanks LD, Simmonds HA et al. 4-Pyridone-3-carboxamide-1-beta-D-ribonucleoside triphosphate (4PyTP), a novel NAD metabolite accumulating in erythrocytes of uremic children: A biomarker for a toxic NAD analogue in other tissues? Toxins 2011; 3: 520-537.
57. Kim MY, Zhang T, Kraus WL. Poly(ADP-ribosyl)ation by PARP-1: 'PARlaying' NAD+ into a nuclear signal. Genes Dev 2005; 19: 1951-1967.
58. Krishnakumar R, Kraus WL. PARP-1 regulates chromatin structure and transcription through a KDM5B-dependent pathway. Mol Cell 2010; 39: 736-749.
59. Meotti FC, Jameson GN, Turner R et al. Urate as a physiological substrate for myeloperoxidase: implications for hyperuricemia and inflammation. J Biol Chem 2011; 286: 12901-12911.
60. Causse E, Ribes D, Longlune N et al. Aminothiols and allantoin in chronic dialysis patients: effects of hemodialysis sessions. Clin Nephrol 2010; 73: 51-57.
61. Shi Y, Evans JE, Rock KL. Molecular identification of a danger signal that alerts the immune system to dying cells. Nature 2003; 425: 516-521.
62. Kono H, Chen CJ, Ontiveros F et al. Uric acid promotes an acute inflammatory response to sterile cell death in mice. J Clin Invest 2010; 120: 1939-1949.
63. Tsalik EL, Langley RJ, Dinwiddie DL et al. An integrated transcriptome and expressed variant analysis of sepsis survival and death. Genome Med 2014; 6: 111.
64. Miller NA, Kingsmore SF, Farmer A et al. Management of High-Throughput DNA Sequencing Projects: Alpheus. J Comput Sci Syst Biol 2008; 1: 132.
65. Saldanha AJ. Java Treeview-extensible visualization of microarray data. Bioinformatics 2004; 20: 3246-3248.